Expiring federal contract
75N98026P00597 — Central Admixture Pharmacy Services, INC
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N98026P00597
- Incumbent
- Central Admixture Pharmacy Services, INC
- Incumbent UEI
- NDPWXJSVYVH9
- Current end date
- May 26, 2027
- Potential total value
- $350,000
- Obligated
- $350,000
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- May 27, 2026
- Place of performance
- CA
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
THE PURPOSE IS TO CONTRACT WITH A SOURCE FOR PROVIDING COMPOUNDING SERVICES TO THE CLINICAL CENTER PHARMACY.
Likely rebid window (estimate)
- Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
- RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325412)
- 75H71226F80004 — Mckesson Corporation · ends November 25, 2026 · $114K
- 75H71224P00137 — Four Points Technology, L.L.C. · ends November 30, 2026 · $240K
- 75H71226F80005 — Mckesson Corporation · ends December 21, 2026 · $1.6M
- 75H71026P00562 — Mckesson Corporation · ends December 31, 2026 · $131K
- 75N92026P00029 — Medunik USA INC · ends December 31, 2026 · $210K
- 75N93024P01131 — United Biopharma, INC. · ends December 31, 2026 · $400K
- 75A50120C00092 — Phlow Corp. · ends January 13, 2027 · $697M
- 75D30123C17978 — Mckesson Specialty Distribution LLC · ends January 31, 2027 · $204M
- 75N95019F00088 — Mriglobal · ends January 31, 2027 · $2.4M
- 75N90024F00080 — Ino Therapeutics LLC · ends February 28, 2027 · $115K